FOGLI, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 935
EU - Europa 616
AS - Asia 275
AF - Africa 33
SA - Sud America 4
OC - Oceania 2
Totale 1.865
Nazione #
US - Stati Uniti d'America 933
GB - Regno Unito 192
SE - Svezia 106
CN - Cina 102
IT - Italia 83
SG - Singapore 70
DE - Germania 69
VN - Vietnam 37
IN - India 32
UA - Ucraina 31
FR - Francia 29
IE - Irlanda 27
RU - Federazione Russa 18
CH - Svizzera 17
JO - Giordania 16
TG - Togo 15
EE - Estonia 12
BG - Bulgaria 11
ZA - Sudafrica 11
FI - Finlandia 8
BE - Belgio 7
JP - Giappone 7
QA - Qatar 4
SC - Seychelles 4
BR - Brasile 3
IR - Iran 3
NL - Olanda 3
AU - Australia 2
HK - Hong Kong 2
AR - Argentina 1
CA - Canada 1
CI - Costa d'Avorio 1
EG - Egitto 1
ID - Indonesia 1
LB - Libano 1
MX - Messico 1
NG - Nigeria 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
Totale 1.865
Città #
Southend 171
Fairfield 107
Chandler 101
Ashburn 81
Woodbridge 75
Seattle 67
Singapore 65
Houston 56
Wilmington 51
Ann Arbor 50
Cambridge 39
Dong Ket 37
Santa Clara 36
Princeton 33
Dublin 27
Boardman 21
Jacksonville 18
Amman 16
Bern 15
Lomé 15
Padova 15
Turin 15
Westminster 15
Nanjing 11
Sofia 11
Beijing 9
Bologna 8
Helsinki 8
San Diego 8
Brussels 7
Berlin 6
Hebei 6
New York 6
Shenyang 6
Bremen 5
Changsha 5
Jinan 5
Doha 4
Farra d'Isonzo 4
Jiaxing 4
Mahé 4
Medford 4
Mountain View 4
Tokyo 4
Washington 4
Kunming 3
Langfang 3
Los Angeles 3
Milan 3
Mülheim 3
Nanchang 3
Negrar 3
Norwalk 3
Saint Petersburg 3
Shanghai 3
Taizhou 3
Verona 3
Zanjan 3
Zhengzhou 3
Bühl 2
Central District 2
Dearborn 2
Falls Church 2
Florence 2
Fuzhou 2
Guangzhou 2
Hangzhou 2
Kuban 2
Leawood 2
London 2
Ningbo 2
Paris 2
Qingdao 2
San Francisco 2
São Paulo 2
Taiyuan 2
Tianjin 2
Ōtemae 2
Abeokuta 1
Abidjan 1
Andover 1
Boydton 1
Buenos Aires 1
Cairo 1
Canberra 1
Catanzaro 1
Changchun 1
Chengdu 1
Chicago 1
Costa Mesa 1
Easton 1
Foshan 1
Frankfurt Am Main 1
Frankfurt am Main 1
Groningen 1
Handan 1
Jakarta 1
Jerzu 1
Lausanne 1
Ljubljana 1
Totale 1.361
Nome #
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 169
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 162
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 144
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib. 142
NUCLEOFECTION IS AN EFFICIENT NON-VIRAL TRANSFECTION TECHNIQUE FOR HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS. 140
Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. 139
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. 137
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 107
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. 106
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse. 104
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors. 103
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engrftment. 102
Treating Ph+ Acute Lymphoblastic Leukemia (ALL) in the Elderly: The Sequence of Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imatinib) Does Not Prevent Mutations and Relapse 96
INTERMITTENT IMATINIB (INTERIM) TREATMENT IN PH+-CML ELDERLY PATIENTS IN STABLE COMPLETE CYTOGENETIC RESPONSE 82
null 81
Differences among young adults, adults and elderly chronic myeloid leukemia patients 60
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation 25
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins 13
Totale 1.912
Categoria #
all - tutte 4.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 52 60 64 61 34 23 33
2020/2021226 48 15 2 19 4 13 4 16 13 26 9 57
2021/2022321 14 9 15 42 26 22 3 23 15 35 65 52
2022/2023377 39 41 21 48 26 33 9 26 69 9 34 22
2023/2024110 6 12 12 15 10 26 6 7 1 4 8 3
2024/2025182 5 42 30 27 67 11 0 0 0 0 0 0
Totale 1.912